1,259 results on '"Lombardi, Carlo"'
Search Results
152. Advanced heart failure: guideline‐directed medical therapy, diuretics, inotropes, and palliative care
153. The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?
154. Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study)
155. Reply to 'Clinical implications of left atrial changes after optimization of medical therapy in heart failure patients'
156. 278 Cardiac involvement in a 23 years old patient with granulomatosis with polyangiitis (GPA)
157. The possible influence of the environment on respiratory allergy: a survey on immigrants to Italy
158. Mode of Death and Hospitalization from the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) Trial and Comparison of Clinical Events Committee Adjudicated Versus Investigator Reported Outcomes
159. Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis
160. The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions
161. 380 Left heart disease phenotype and use of pulmonary vasodilators in elderly patients with pulmonary arterial hypertension: the Patriarca registry
162. 261 A case of metastatic myxoid liposarcoma causing cardiac tamponade
163. 484 Echocardiographic patterns in patients with apolipoprotein AI amyloidosis
164. 128 Clinical impact of changes in mitral regurgitation severity after optimization of medical therapy in heart failure: insights from BIOSTAT-CHF
165. 132 Clinical characteristics and outcomes of a contemporary, real-world, single-centre cohort of patients with advanced heart failure
166. 192 Study of endothelial function and vascular stiffness in patients affected by dilated cardiomyopathy on treatment with sacubitril/valsartan
167. 267 Cardiac biomarkers and mortality in COVID-19 infection
168. 566 Transthyretin and light-chain cardiac amyloidosis: clinical characteristics, echocardiographic findings, and outcomes of a large cohort of patients in Northern Italy
169. 632 Diagnostic and prognostic performance of HFA-PEFF and H2FpEF scores in patients with cardiac amyloidosis
170. 554 Machine learning for prediction of in-hospital mortality in COVID-19 patients: results from an Italian multicentre study
171. Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper
172. Severe asthma: One disease and multiple definitions
173. Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group
174. Value of the HFA‐PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis.
175. ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments
176. Acute heart failure: Multiple clinical profiles and mechanisms require tailored therapy
177. Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study
178. ARIA (Allergic Rhinitis and its Impact on Asthma) 2019. Percorsi di cura per la rinite allergica – ITALIA
179. ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy
180. Creatine deficiency and heart failure
181. A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization — the first insight from the AC-TIVE Study
182. Prevalence and features of IOS-defined small airway disease across asthma severities
183. Unified macro-to-microscale method to predict two-phase frictional pressure drops of annular flows
184. Algebraic turbulence modeling in adiabatic gas–liquid annular two-phase flow
185. La triplice terapia in un unico inalatore (SITT) nell’asma.
186. Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study
187. The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction
188. The prognostic value of serial troponin measurements in patients admitted for COVID‐19
189. Metrological Characterization of Ground-based Sensors for Space Surveillance and Tracking
190. L’Oscillometria a impulsi nuovo test di funzionalità respiratoria per i bambini con asma
191. Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension
192. Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis
193. Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation
194. Can we prevent or treat renal dysfunction in acute heart failure?
195. Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment
196. Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia: A single-center, retrospective study
197. Use of Inotropic Agents in Patients with Advanced Heart Failure: Lessons from Recent Trials and Hopes for New Agents
198. Role of Beta-Adrenergic Receptor Gene Polymorphisms in the Long-Term Effects of Beta-Blockade with Carvedilol in Patients with Chronic Heart Failure
199. Clinical-economic impact of mepolizumab in patients with severe hypereosinophilic asthma
200. A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian multicenter study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.